Cargando…

Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan

The agricultural biotechnology world has been divided into two blocks; countries adopting GM crops for commercial cultivation (adopters) and others without any or without relevant cultivation of such crops (non-adopters). Meanwhile, an increasing number of adopter countries have exempted certain gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Spök, Armin, Sprink, Thorben, Allan, Andrew C., Yamaguchi, Tomiko, Dayé, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473316/
https://www.ncbi.nlm.nih.gov/pubmed/36120531
http://dx.doi.org/10.3389/fgeed.2022.899331
_version_ 1784789477533679616
author Spök, Armin
Sprink, Thorben
Allan, Andrew C.
Yamaguchi, Tomiko
Dayé, Christian
author_facet Spök, Armin
Sprink, Thorben
Allan, Andrew C.
Yamaguchi, Tomiko
Dayé, Christian
author_sort Spök, Armin
collection PubMed
description The agricultural biotechnology world has been divided into two blocks; countries adopting GM crops for commercial cultivation (adopters) and others without any or without relevant cultivation of such crops (non-adopters). Meanwhile, an increasing number of adopter countries have exempted certain genome-edited (GE) crops from legal GMO pre-market approval and labelling requirements. Among them are major exporters of agricultural commodities such as United States, Canada, and Australia. Due to the relaxed legislation more GE plants are expected to enter the market soon. Many countries in the non-adopter group, however, depend on import of large volumes of agricultural commodities from adopter countries. Unlike first generation GM, certain GE crops cannot be identified as unambiguously originating from genome editing using available techniques. Consequently, pressure is mounting on non-adopter jurisdictions to reconsider their policies and legislations. Against this backdrop, the paper explores recent developments relevant for social acceptability in selected non-adopters, Japan, New Zealand, the EU, Norway, and Switzerland in contrast to United States, Canada, and Australia. While Japan is already opening-up and Norway and Switzerland are discussing revisions of their policies, the EU and New Zealand are struggling with challenges resulting from high court decisions. In an attempt to take a closer look into the inner dynamics of these developments, the concept of social acceptability proposed by Wüstenhagen et al. (Energy Policy, 2007, 35(5), 2683–2691) is employed. This aids the understanding of developments in the jurisdictions considered and identifies specific or cross-cutting challenges.
format Online
Article
Text
id pubmed-9473316
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94733162022-09-15 Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan Spök, Armin Sprink, Thorben Allan, Andrew C. Yamaguchi, Tomiko Dayé, Christian Front Genome Ed Genome Editing The agricultural biotechnology world has been divided into two blocks; countries adopting GM crops for commercial cultivation (adopters) and others without any or without relevant cultivation of such crops (non-adopters). Meanwhile, an increasing number of adopter countries have exempted certain genome-edited (GE) crops from legal GMO pre-market approval and labelling requirements. Among them are major exporters of agricultural commodities such as United States, Canada, and Australia. Due to the relaxed legislation more GE plants are expected to enter the market soon. Many countries in the non-adopter group, however, depend on import of large volumes of agricultural commodities from adopter countries. Unlike first generation GM, certain GE crops cannot be identified as unambiguously originating from genome editing using available techniques. Consequently, pressure is mounting on non-adopter jurisdictions to reconsider their policies and legislations. Against this backdrop, the paper explores recent developments relevant for social acceptability in selected non-adopters, Japan, New Zealand, the EU, Norway, and Switzerland in contrast to United States, Canada, and Australia. While Japan is already opening-up and Norway and Switzerland are discussing revisions of their policies, the EU and New Zealand are struggling with challenges resulting from high court decisions. In an attempt to take a closer look into the inner dynamics of these developments, the concept of social acceptability proposed by Wüstenhagen et al. (Energy Policy, 2007, 35(5), 2683–2691) is employed. This aids the understanding of developments in the jurisdictions considered and identifies specific or cross-cutting challenges. Frontiers Media S.A. 2022-08-31 /pmc/articles/PMC9473316/ /pubmed/36120531 http://dx.doi.org/10.3389/fgeed.2022.899331 Text en Copyright © 2022 Spök, Sprink, Allan, Yamaguchi and Dayé. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genome Editing
Spök, Armin
Sprink, Thorben
Allan, Andrew C.
Yamaguchi, Tomiko
Dayé, Christian
Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan
title Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan
title_full Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan
title_fullStr Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan
title_full_unstemmed Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan
title_short Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan
title_sort towards social acceptability of genome-edited plants in industrialised countries? emerging evidence from europe, united states, canada, australia, new zealand, and japan
topic Genome Editing
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473316/
https://www.ncbi.nlm.nih.gov/pubmed/36120531
http://dx.doi.org/10.3389/fgeed.2022.899331
work_keys_str_mv AT spokarmin towardssocialacceptabilityofgenomeeditedplantsinindustrialisedcountriesemergingevidencefromeuropeunitedstatescanadaaustralianewzealandandjapan
AT sprinkthorben towardssocialacceptabilityofgenomeeditedplantsinindustrialisedcountriesemergingevidencefromeuropeunitedstatescanadaaustralianewzealandandjapan
AT allanandrewc towardssocialacceptabilityofgenomeeditedplantsinindustrialisedcountriesemergingevidencefromeuropeunitedstatescanadaaustralianewzealandandjapan
AT yamaguchitomiko towardssocialacceptabilityofgenomeeditedplantsinindustrialisedcountriesemergingevidencefromeuropeunitedstatescanadaaustralianewzealandandjapan
AT dayechristian towardssocialacceptabilityofgenomeeditedplantsinindustrialisedcountriesemergingevidencefromeuropeunitedstatescanadaaustralianewzealandandjapan